MLL chimeric protein activation renders cells vulnerable to chromosomal damage: An explanation for the very short latency of infant leukemia
- 10 May 2006
- journal article
- research article
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 45 (8) , 754-760
- https://doi.org/10.1002/gcc.20338
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Molecular Pathogenesis of MLL-Associated LeukemiasInternational Journal of Hematology, 2005
- Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoproteinLeukemia, 2004
- Leukemia in twins: lessons in natural historyBlood, 2003
- Molecular mechanisms of leukemogenesis mediated by MLL fusion proteinsOncogene, 2001
- Biological and therapeutic aspects of infant leukemiaBlood, 2000
- Leukemic HRX Fusion Proteins Inhibit GADD34-Induced Apoptosis and Associate with the GADD34 and hSNF5/INI1 ProteinsMolecular and Cellular Biology, 1999
- Secondary leukemias induced by topoisomerase-targeted drugsBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998
- Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spotsProceedings of the National Academy of Sciences, 1997
- An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion OncogenesCell, 1996
- In utero rearrangements in the trithorax-related oncogene in infant leukaemiasNature, 1993